XARELTO Market, By Indications (Nonvalvular Atrial Fibrillation (AF), Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Recurrent DVT or PE, Pos Knee or Hip Replacement Surgery, Venous Thromboembolism (VTE) in Acutely Ill Patients, Pediatric VTE, Coronary Artery Disease (CAD), Peripheral Artery Disease (PAD), and Post-Fontan Procedure in Congenital Heart Disease (CHD)), By Dosage Form (Tablets and Oral Suspension), By Strength (2.5 mg, 10 mg, 15 mg, 20 mg, and 1 mg/mL), By Age Group (Pediatric, Adult, and Geriatric), By Gender (Male and Female), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others (Academic and Research Institutes, etc.)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
선택하다 귀사의 비즈니스 요구 사항에 맞는 라이센스 유형
US$ 2,200
이천이백 달러
단일 사용자 라이센스
( 전체 보고서 )
US$ 4,500
US$ 3,000
Three thousand dollars
자주 구매되는 상품
다중 사용자 라이센스
(전체 보고서)
US$ 7,000
US$ 5,000
Five thousand dollars
기업 사용자 라이센스
(전체 보고서)
US$ 10,000
US$ 6000
Six thousand dollars
Client Testimonials
Client Testimonials
우리의 고객